{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:42:04Z","timestamp":1792590124827,"version":"4.5.0"},"reference-count":20,"publisher":"Pan American Health Organization","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,29]]},"abstract":"<p>\n                    <italic>An emerging mosquito-borne flavivirus, Zika virus (ZIKV) is a significant public health concern because of the syndromes associated with the infection. In addition, ZIKV is considered a major problem due to large-scale spread of the disease and the possible clinical complications for the central nervous system, especially Guillain-Barr\u00e9 syndrome (GBS) and microcephaly. Since the introduction of ZIKV in the Caribbean, molecular detection of the viral RNA has been utilized as a more specific and sensitive approach to demonstrating acute infection. However, it is generally accepted that the virus has a short viremic period, generally less than 5 days. Serologic testing has the inconvenience of strong cross-reactivity among flaviviruses, such as dengue and yellow fever. As part of the laboratory surveillance activities for Zika and other arboviruses at the Caribbean Public Health Agency, in 2016 a sample from a male who was clinically diagnosed with GBS tested positive for Zika virus by real-time polymerase chain reaction (rRT-PCR). The serum sample had been taken on day 21 after the onset of symptoms. The case had initially been characterized as a typical ZIKV infection (mild fever with a generalized maculopapular rash). Later, weakness of limbs and other peripheral neurological symptoms appeared. Enzyme-linked immunoassay (ELISA) showed that the sample was negative for IgM antibodies against Zika, Chikungunya, and dengue viruses. The plaque reduction neutralization test was positive for ZIKV. This indicated parallel development of viremia and immune response against ZIKV. Recent reports have demonstrated a longer duration of the viremia in ZIKV infections. However, our report is the first one that links the infection with extended viremia and the development in parallel of a GBS case<\/italic>\n                    .\n                  <\/p>","DOI":"10.26633\/rpsp.2017.136","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T10:58:13Z","timestamp":1563793093000},"page":"1","source":"Crossref","is-referenced-by-count":5,"title":["Prolonged Zika virus viremia in a patient with Guillain-Barr\u00e9 syndrome in Trinidad and Tobago"],"prefix":"10.26633","volume":"41","author":[{"given":"Gabriel","family":"Gonzalez-Escobar","sequence":"first","affiliation":[{"name":"Caribbean Public Health Agency (CARPHA), Port of Spain, Trinidad and Tobago."},{"name":"escobaga@carpha.org"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Marie Valadere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosmond","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Polson-Edwards","sequence":"additional","affiliation":[{"name":"Caribbean Public Health Agency (CARPHA), Port of Spain, Trinidad and Tobago."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery Q.J.","family":"Hinds","sequence":"additional","affiliation":[{"name":"Caribbean Public Health Agency (CARPHA), Port of Spain, Trinidad and Tobago."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akenath","family":"Misir","sequence":"additional","affiliation":[{"name":"Ministry of Health, Port of Spain, Trinidad and Tobago."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. James","family":"Hospedales","sequence":"additional","affiliation":[{"name":"Caribbean Public Health Agency (CARPHA), Port of Spain, Trinidad and Tobago."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11167","reference":[{"key":"ref1","unstructured":"1. Gubler DJ, Kuno G, Markoff L. Flaviviruses. In: Knipe DM, Howley PM, eds. Fields virology, 5\n                      th\n                      ed. Philadelphia: Lippincott Williams & Wilkins; 2007:1155\u2013227."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952 Sep; 46(5):509\u201320.","DOI":"10.1016\/0035-9203(52)90042-4"},{"key":"ref3","unstructured":"3. Haddow AJ, Williams MC, Woodal JP, Simpson DI, Goma LK. Twelve isolations of Zika virus from Aedes (Stegomyia) africanus (Theobald) taken in and above a Uganda forest. Bull World Health Organ. 1964;31:57\u201369."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Duffy MR, Chen T-H, Hancock WT, Hancock T, Powers AM, Kool JL, et al. Zika virus outbreak on Yap island, Federated States of Micronesia. N Engl J Med. 2009 Jun 11;360(24):2536\u201343.","DOI":"10.1056\/NEJMoa0805715"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Sejvar JJ, Bode AV, Marfin AA, Campbell GL, Ewing D, Mazowiecki M, et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis. 2005;11:2021\u20137.","DOI":"10.3201\/eid1107.040991"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Cao-Lormeau VM, Blake A, Mons S, Last\u00e8re S, Roche C, Vanhomwegen J, et al. Guillain-Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387:1531\u20139.","DOI":"10.1016\/S0140-6736(16)00562-6"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Dos Santos T, Rodriguez A, Almiron M, Sanhueza A, Ramon P, De Oliveira W, et al. Zika virus and the Guillain-Barr\u00e9 syndrome -case series from seven countries. N Engl J Med. 2016 Oct 20;375(16):1598\u20131601.","DOI":"10.1056\/NEJMc1609015"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Kassavetis P, Bajo J-M, Perloff MD, Roosevelt F, Berkowitz AL. Zika virus-associated Guillain-Barr\u00e9 syndrome variant in Haiti. Am Acad Neurol. 2016;87:336\u20137.","DOI":"10.1212\/WNL.0000000000002759"},{"key":"ref9","unstructured":"9. Pan American Health Organization. Guidelines for Zika virus disease and its complications 2016. Washington, D.C.: PAHO, 2016. Available from: http:\/\/iris.paho.org\/xmlui\/bitstream\/handle\/123456789\/28405\/9789275118948_eng.pdf?sequ-ence=1&isAllowed=y Accessed 10 May 2017."},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14:1232\u20139.","DOI":"10.3201\/eid1408.080287"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Bearcroft WG. Zika virus infection experimentally induced in a human volunteer. Trans R Soc Trop Med Hyg. 1956;50:442\u20138.","DOI":"10.1016\/0035-9203(56)90090-6"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Meaney-Delman D, Oduyebo T, Polen KN, White JLWhite JL, Bingham AM, Slavinski SA, et al. Prolonged detection of Zika virus RNA in pregnant women. Obstet Gynecol. 2016;128(4):724\u201330.","DOI":"10.1097\/AOG.0000000000001625"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Driggers RW, Ho CY, Korhonen EM, Kuivanen S, J\u00e4\u00e4skel\u00e4inen AJ, Smura T, et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med. 2016;374:2142\u201351.","DOI":"10.1056\/NEJMoa1601824"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Paz-Bailey G, Rosenberg ES, Doyle K, Mu\u00f1oz-Jordan J, Santiago GA, Klein L, et al. Persistence of Zika virus in body fluids \u2013 preliminary report. N Engl J Med. 2017 Feb 14. doi: 10.1056\/NEJMoa1613108 [Epub ahead of print].","DOI":"10.1056\/NEJMoa1613108"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Steinhagen K, Probst C, Radzimski C, Schmidt-Chanasit J, Emmerich P, van Esbroeck M, et al. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016. Euro Surveill. 2016 Dec 15;21(50):30426.","DOI":"10.2807\/1560-7917.ES.2016.21.50.30426"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Kumar M, Roe K, Nerurkar PV, Namekar M, Orillo B, Verma S, et al. Impaired virus clearance, compromised immune response and increased mortality in type 2 diabetic mice infected with West Nile virus. PLoS One. 2012;7(8):e44682. 10.1371\/journal.pone.0044682.","DOI":"10.1371\/journal.pone.0044682"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Dejnirattisai W, Supasa P, Wongwiwat W,Rouvinski A, Barba-Spaeth G, Duangchinda T, et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol. 2016 Sep;17(9):1102\u20138. 10.1038\/ni.3515.","DOI":"10.1038\/ni.3515"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J, Edupuganti S, et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Nat Acad Sci. 2016;113(28):7852\u20137.","DOI":"10.1073\/pnas.1607931113"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Paul LM, Carlin ER, Jenkins MM, Tan AL, Barcellona CM, Nicholson CO, et al. Dengue virus antibodies enhance Zika virus infection. Available from: http:\/\/biorxiv.org\/content\/early\/2016\/04\/25\/050112 Accessed 10 May 2017.","DOI":"10.1101\/050112"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Oliveira DBL, Almeida FJ, Durigon EL, Mendes EA, Braconi CT, Marchetti I, et al. Prolonged shedding of Zika virus associated with congenital infection. N Engl J Med. 2016;375:12\u201314.","DOI":"10.1056\/NEJMc1607583"}],"container-title":["Revista Panamericana de Salud P\u00fablica"],"original-title":[],"language":"es","link":[{"URL":"http:\/\/iris.paho.org\/xmlui\/bitstream\/handle\/123456789\/34331\/v41a1362017.pdf?sequence=1&isAllowed=y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T14:22:33Z","timestamp":1572618153000},"score":1,"resource":{"primary":{"URL":"http:\/\/iris.paho.org\/xmlui\/handle\/123456789\/34331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":20,"alternative-id":["RPSP.2017.136"],"URL":"https:\/\/doi.org\/10.26633\/rpsp.2017.136","relation":{},"ISSN":["1020-4989","1680-5348"],"issn-type":[{"value":"1020-4989","type":"print"},{"value":"1680-5348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]}}}